Lattice Biologics Raises $0.75MM in Private Placement

Lattice Biologics closed a private placement for gross proceeds of up to US $0.75MM. Proceeds will fund M&A and the acquisition of amnion donors to support production of an amniotic fluid product for regenerative use.

The novel regenerative therapeutic will target osteoarthritis, spine, sports-medicine, foot/ankle and other indications. The...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0